España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Nevro
NVRO
NYSE
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$9.50
0.4
4.40%
At Close: -
$9.50
0
0.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Q2 2024 Earnings in 15 days from now on Tue Aug 6th, after the market close
Nevro (NVRO) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Nevro (NYSE:NVRO) Stock
Nevro Stock (NYSE: NVRO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, July 16, 2024
Truist Securities Maintains Hold on Nevro, Lo...
Benzinga Newsdesk
Monday, July 15, 2024
Beyond The Numbers: 6 Analysts Discuss Nevro Stock
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on Nevr...
Benzinga Newsdesk
Thursday, July 11, 2024
Citigroup Maintains Sell on Nevro, Lowers Pri...
Benzinga Newsdesk
Wednesday, May 22, 2024
Citigroup Downgrades Nevro to Sell, Lowers Pr...
Benzinga Newsdesk
Wednesday, May 08, 2024
Assessing Nevro: Insights From 9 Financial Analysts
Benzinga Insights
Canaccord Genuity Maintains Hold on Nevro, Lo...
Benzinga Newsdesk
Wells Fargo Maintains Equal-Weight on Nevro, ...
Benzinga Newsdesk
Piper Sandler Maintains Underweight on Nevro,...
Benzinga Newsdesk
Tuesday, May 07, 2024
Nevro Reaffirms FY24 Revenue Guidance Of $435...
Benzinga Newsdesk
Nevro Q1 2024 GAAP EPS $(0.70) Beats $(1.08) ...
Benzinga Newsdesk
Monday, April 15, 2024
RBC Capital Maintains Sector Perform on Nevro...
Benzinga Newsdesk
Thursday, April 11, 2024
Mizuho Maintains Neutral on Nevro, Lowers Pri...
Benzinga Newsdesk
Monday, April 08, 2024
Wells Fargo Maintains Equal-Weight on Nevro, ...
Benzinga Newsdesk
Wednesday, April 03, 2024
Where Nevro Stands With Analysts
Benzinga Insights
Citigroup Maintains Neutral on Nevro, Lowers ...
Benzinga Newsdesk
Wednesday, February 28, 2024
Nevro Receives FDA 510(k) Clearance To Use SI...
Benzinga Newsdesk
Thursday, February 22, 2024
Analyst Scoreboard: 4 Ratings For Nevro
Benzinga Insights
Wednesday, February 21, 2024
Nevro Expects Worldwide Revenue Of $435M-$445...
Benzinga Newsdesk
Nevro Enters Cooperation Agreement With Engag...
Benzinga Newsdesk
Nevro Q4 2023 GAAP EPS $(0.25) Beats $(0.49) ...
Benzinga Newsdesk
Nevro: Q4 Earnings Insights
Benzinga Insights
Earnings Scheduled For February 21, 2024
Benzinga Insights
Thursday, January 18, 2024
Nevro Announces Coverage Update From Carelon ...
Benzinga Newsdesk
Wednesday, January 17, 2024
Nevro To Highlight 25 Scientific Abstracts At...
Benzinga Newsdesk
Friday, January 12, 2024
What Analysts Are Saying About Nevro Stock
Benzinga Insights
RBC Capital Downgrades Nevro to Sector Perfor...
Benzinga Newsdesk
Tuesday, January 09, 2024
Nevro Announces Restructuring, Including Layi...
Benzinga Newsdesk
Nevro Sees Prelim. FY23 Revenue $425M Vs $418...
Benzinga Newsdesk
Nevro Sees Prelim. Q4 Revenue $116M Vs $109.2...
Benzinga Newsdesk
Friday, December 29, 2023
Nevro Filed Prospectus For Offering Of Up To 2.5M Shares Of Common Stock Offered By Selling Securityholde
Charles Gross
Friday, December 22, 2023
Truist Securities Maintains Hold on Nevro, Ra...
Benzinga Newsdesk
Thursday, December 21, 2023
Forecasting The Future: 6 Analyst Projections For Nevro
Benzinga Insights
Canaccord Genuity Downgrades Nevro to Hold, A...
Benzinga Newsdesk
Friday, December 01, 2023
Where Nevro Stands With Analysts
Benzinga Insights
RBC Capital Reiterates Outperform on Nevro, M...
Benzinga Newsdesk
Thursday, November 30, 2023
Nevro Acquires Vyrsa Technologies; Paid $40M ...
Benzinga Newsdesk
Thursday, November 02, 2023
JP Morgan Maintains Neutral on Nevro, Lowers ...
Benzinga Newsdesk
What 4 Analyst Ratings Have To Say About Nevro
Benzinga Insights
Piper Sandler Maintains Underweight on Nevro,...
Benzinga Newsdesk
Truist Securities Maintains Hold on Nevro, Lo...
Benzinga Newsdesk
Morgan Stanley Maintains Equal-Weight on Nevr...
Benzinga Newsdesk
Wednesday, November 01, 2023
Nevro Q3 2023 Gaap EPS $(0.65) Beats $(0.77) ...
Benzinga Newsdesk
Earnings Scheduled For November 1, 2023
Benzinga Insights
Tuesday, October 31, 2023
Earnings Preview For Nevro
Benzinga Insights
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Monday, September 18, 2023
Nevro Announced The Publication Of New Data V...
Benzinga Newsdesk
Tuesday, August 22, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, August 21, 2023
What 21 Analyst Ratings Have To Say About Nevro
Benzinga Insights
Citigroup Maintains Neutral on Nevro, Lowers ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
